"Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility". European Journal of Pharmacology. 411 (3): 289-99. Ocak 2001. doi:10.1016/S0014-2999(00)00897-9. PMID11164387.
"Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells". European Journal of Pharmacology. 481 (1): 41-50. Kasım 2003. doi:10.1016/j.ejphar.2003.09.013. PMID14637173.
"Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors". European Journal of Pharmacology. 332 (2): 183-93. Ağustos 1997. doi:10.1016/S0014-2999(97)01073-X. PMID9286620.
nih.gov
ncbi.nlm.nih.gov
"Mechanisms of blockade by the novel migraine prophylactic agent, dotarizine, of various brain and peripheral vessel contractility". European Journal of Pharmacology. 411 (3): 289-99. Ocak 2001. doi:10.1016/S0014-2999(00)00897-9. PMID11164387.
"Antimigraine dotarizine blocks P/Q Ca2+ channels and exocytosis in a voltage-dependent manner in chromaffin cells". European Journal of Pharmacology. 481 (1): 41-50. Kasım 2003. doi:10.1016/j.ejphar.2003.09.013. PMID14637173.
"Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration". Methods and Findings in Experimental and Clinical Pharmacology. 19 (5): 343-50. Haziran 1997. PMID9379783.
"Serotonergic effects of dotarizine in coronary artery and in oocytes expressing 5-HT2 receptors". European Journal of Pharmacology. 332 (2): 183-93. Ağustos 1997. doi:10.1016/S0014-2999(97)01073-X. PMID9286620.